(Q35115741)

English

Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

18

object named as

Patrick Hwu

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Richard W. Joseph

1 reference

ORCID Public Data File 2021

author name string

Richard W Joseph

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Vijay R Peddareddigari

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ping Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Priscilla W Miller

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Willem W Overwijk

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Nebiyou B Bekele

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Merrick I Ross

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jeffrey E Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jeffrey E Gershenwald

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Anthony Lucci

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Victor G Prieto

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

John D McMannis

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Nicholas Papadopoulos

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kevin Kim

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jade Homsi

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Agop Bedikian

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Wen-Jen Hwu

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Laszlo G Radvanyi

19

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

4882-4891

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Thymic involution and immune reconstitution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Assessing ageing of individual T lymphocytes: mission impossible?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

T cell immune reconstitution following lymphodepletion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Somatic activation of KIT in distinct subtypes of melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Immunosuppression in melanoma immunotherapy: potential opportunities for intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Distinct sets of genetic alterations in melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

The extent and significance of telomere loss with age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Sex hormones and the immune system--Part 2. Animal data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

9 July 2018

Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

27 September 2018

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

27 September 2018

Characterization of tumor-infiltrating lymphocytes derived from human tumors for use as adoptive immunotherapy of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3139726

27 September 2018

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/21632855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis in women: Incidence rates in group health cooperative, seattle, washington, 1987-1989

1 reference

https://pubmed.ncbi.nlm.nih.gov/21632855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21632855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-10-2769

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35115741&oldid=1981114783"